These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


181 related items for PubMed ID: 11408373

  • 1. Role of CYP2C9 polymorphism in losartan oxidation.
    Yasar U, Tybring G, Hidestrand M, Oscarson M, Ingelman-Sundberg M, Dahl ML, Eliasson E.
    Drug Metab Dispos; 2001 Jul; 29(7):1051-6. PubMed ID: 11408373
    [Abstract] [Full Text] [Related]

  • 2. Role of cytochrome P-4502C9 in irbesartan oxidation by human liver microsomes.
    Bourrié M, Meunier V, Berger Y, Fabre G.
    Drug Metab Dispos; 1999 Feb; 27(2):288-96. PubMed ID: 9929518
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of losartan and its metabolite E-3174 in relation to the CYP2C9 genotype.
    Yasar U, Forslund-Bergengren C, Tybring G, Dorado P, Llerena A, Sjöqvist F, Eliasson E, Dahl ML.
    Clin Pharmacol Ther; 2002 Jan; 71(1):89-98. PubMed ID: 11823761
    [Abstract] [Full Text] [Related]

  • 4. The role of CYP2C9 genotype in the metabolism of diclofenac in vivo and in vitro.
    Yasar U, Eliasson E, Forslund-Bergengren C, Tybring G, Gadd M, Sjöqvist F, Dahl ML.
    Eur J Clin Pharmacol; 2001 Dec; 57(10):729-35. PubMed ID: 11829203
    [Abstract] [Full Text] [Related]

  • 5. Biotransformation of losartan to its active carboxylic acid metabolite in human liver microsomes. Role of cytochrome P4502C and 3A subfamily members.
    Stearns RA, Chakravarty PK, Chen R, Chiu SH.
    Drug Metab Dispos; 1995 Feb; 23(2):207-15. PubMed ID: 7736913
    [Abstract] [Full Text] [Related]

  • 6. Enantiospecific effects of cytochrome P450 2C9 amino acid variants on ibuprofen pharmacokinetics and on the inhibition of cyclooxygenases 1 and 2.
    Kirchheiner J, Meineke I, Freytag G, Meisel C, Roots I, Brockmöller J.
    Clin Pharmacol Ther; 2002 Jul; 72(1):62-75. PubMed ID: 12152005
    [Abstract] [Full Text] [Related]

  • 7. Substrate-dependent effect of acetonitrile on human liver microsomal cytochrome P450 2C9 (CYP2C9) activity.
    Tang C, Shou M, Rodrigues AD.
    Drug Metab Dispos; 2000 May; 28(5):567-72. PubMed ID: 10772636
    [Abstract] [Full Text] [Related]

  • 8. Substrate-dependent functional alterations of seven CYP2C9 variants found in Japanese subjects.
    Maekawa K, Harakawa N, Sugiyama E, Tohkin M, Kim SR, Kaniwa N, Katori N, Hasegawa R, Yasuda K, Kamide K, Miyata T, Saito Y, Sawada J.
    Drug Metab Dispos; 2009 Sep; 37(9):1895-903. PubMed ID: 19541829
    [Abstract] [Full Text] [Related]

  • 9. Comparative studies on the catalytic roles of cytochrome P450 2C9 and its Cys- and Leu-variants in the oxidation of warfarin, flurbiprofen, and diclofenac by human liver microsomes.
    Yamazaki H, Inoue K, Chiba K, Ozawa N, Kawai T, Suzuki Y, Goldstein JA, Guengerich FP, Shimada T.
    Biochem Pharmacol; 1998 Jul 15; 56(2):243-51. PubMed ID: 9698079
    [Abstract] [Full Text] [Related]

  • 10. Cytochrome P4502C9 genotype in Southeast Anatolia and possible relation with some serum tumour markers and cytokines.
    Yilmaz N, Erbağci AB, Aynacioğlu AS.
    Acta Biochim Pol; 2001 Jul 15; 48(3):775-82. PubMed ID: 11833786
    [Abstract] [Full Text] [Related]

  • 11. Impact of CYP2C9 amino acid polymorphisms on glyburide kinetics and on the insulin and glucose response in healthy volunteers.
    Kirchheiner J, Brockmöller J, Meineke I, Bauer S, Rohde W, Meisel C, Roots I.
    Clin Pharmacol Ther; 2002 Apr 15; 71(4):286-96. PubMed ID: 11956512
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of potential losartan-phenytoin drug interactions in healthy volunteers.
    Fischer TL, Pieper JA, Graff DW, Rodgers JE, Fischer JD, Parnell KJ, Goldstein JA, Greenwood R, Patterson JH.
    Clin Pharmacol Ther; 2002 Sep 15; 72(3):238-46. PubMed ID: 12235444
    [Abstract] [Full Text] [Related]

  • 13. Interindividual variability in sensitivity to warfarin--Nature or nurture?
    Loebstein R, Yonath H, Peleg D, Almog S, Rotenberg M, Lubetsky A, Roitelman J, Harats D, Halkin H, Ezra D.
    Clin Pharmacol Ther; 2001 Aug 15; 70(2):159-64. PubMed ID: 11503010
    [Abstract] [Full Text] [Related]

  • 14. Inhibition by atovaquone of CYP2C9-mediated sulphamethoxazole hydroxylamine formation.
    Miller JL, Trepanier LA.
    Eur J Clin Pharmacol; 2002 Apr 15; 58(1):69-72. PubMed ID: 11956677
    [Abstract] [Full Text] [Related]

  • 15. [Relationship of polymorphism in CYP2C9 to genetic susceptibility to diclofenac-induced influenza-virus-associated encephalopathy].
    Funato T, Kozawa K, Kaku M.
    Rinsho Byori; 2002 Feb 15; 50(2):140-5. PubMed ID: 11925850
    [Abstract] [Full Text] [Related]

  • 16. CYP2C8/9 mediate dapsone N-hydroxylation at clinical concentrations of dapsone.
    Winter HR, Wang Y, Unadkat JD.
    Drug Metab Dispos; 2000 Aug 15; 28(8):865-8. PubMed ID: 10901692
    [Abstract] [Full Text] [Related]

  • 17. Interindividual variability in ibuprofen pharmacokinetics is related to interaction of cytochrome P450 2C8 and 2C9 amino acid polymorphisms.
    García-Martín E, Martínez C, Tabarés B, Frías J, Agúndez JA.
    Clin Pharmacol Ther; 2004 Aug 15; 76(2):119-27. PubMed ID: 15289789
    [Abstract] [Full Text] [Related]

  • 18. Relationship of polymorphism in CYP2C9 to genetic susceptibility to diclofenac-induced hepatitis.
    Aithal GP, Day CP, Leathart JB, Daly AK.
    Pharmacogenetics; 2000 Aug 15; 10(6):511-8. PubMed ID: 10975605
    [Abstract] [Full Text] [Related]

  • 19. Stimulation of tolbutamide hydroxylation by acetone and acetonitrile in human liver microsomes and in a cytochrome P-450 2C9-reconstituted system.
    Palamanda J, Feng WW, Lin CC, Nomeir AA.
    Drug Metab Dispos; 2000 Jan 15; 28(1):38-43. PubMed ID: 10611138
    [Abstract] [Full Text] [Related]

  • 20. Rapid detection of CYP2C9*3 alleles by real-time fluorescence PCR based on SYBR Green.
    Hiratsuka M, Agatsuma Y, Mizugaki M.
    Mol Genet Metab; 1999 Nov 15; 68(3):357-62. PubMed ID: 10562462
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.